v3.26.1
Subsequent Events (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Subsequent Events [Abstract]    
Schedule of Revenue by Geographic Region

The Company’s disaggregation of revenue by major product offering is consistent with its presentation on the Company’s consolidated statements of operations. The table below provides the Company’s total revenue by geographic region based on the location of the customer (in thousands):

 

   2026   2025 
  

Three Months Ended

March 31,

 
   2026   2025 
Americas  $91   $119 
Rest of World   5    18 
Total  $96   $137 

The Company’s disaggregation of revenue by major product offering is consistent with its presentation on the Company’s consolidated statements of operations. The table below provides the Company’s total revenue by geographic region based on the location of the customer (in thousands):

  

   2025   2024 
   Year Ended December 31, 
   2025   2024 
Americas  $608   $401 
Europe and Middle East   695    242 
Asia Pacific   56    - 
Total  $1,359   $643 
Schedule of Aggregate Percentage Revenue and Accounts Receivable  

   2025   2024 
   Year Ended December 31, 
   2025   2024 
Customer 1   21%   - %
Customer 2   15%   - %
Customer 3   12%   - %
Customer 4   - %   35%
Customer 5   -%   17%
Aggregate percent of revenue   48%   52%

 

As of December 31, 2025, there were three customers that accounted for more than 10% of the Company’s accounts receivable balance. As of December 31, 2024, there were two customers that accounted for more than 10% of the Company’s accounts receivable balance. The following table represents these customers’ aggregate percentage of total accounts receivable:

 

   2025   2024 
   As of December 31, 
   2025   2024 
Customer 1   18%   -%
Customer 2   17%   -37%
Customer 3   16%   -%
Customer 4   -%   17%
Aggregate percent of accounts receivable   51%   54%
Schedule of Antidilutive Earnings Per Share

 

   2026   2025 
   Three Months Ended March 31, 
   2026   2025 
Restricted stock units   2,099,586    1,912,895 
Warrants for Common Stock   12,364,114    12,364,114 
Convertible debt   -    5,468,831 
Deferred underwriter fees   -    3,174,999 
Loan extensions   330,000    3,274,182 
Total common stock equivalents   14,793,700    26,195,021 

As a result of the Company reporting net loss attributable to common stockholders for all periods presented herein, the following common stock equivalents were excluded from the computation of diluted net loss per common share for the years ended December 31, 2025 and 2024 because including them would have been antidilutive (in thousands):

 

 

   2025   2024 
   Year Ended December 31, 
   2025   2024 
Restricted stock units   3,211,252    1,625,404 
Convertible debt   -    8,549,417 
Warrants for common stock   12,314,114    12,364,114 
Deferred underwriter fees   -    3,174,999 
Loan extensions   330,000    3,274,182 
Total common stock equivalents   15,855,366    28,988,116